STAT+: For-profit biomedical institute, backed by billionaires, launches in Cambridge to speed drug discovery
A team of high-powered scientists and billionaire investors said Friday that they’re launching a biomedical…
Category: drug discovery
STAT+: Machine learning biotech raises $273 million in rare successful late-stage round
Biotech startup Generate Biomedicines, which uses artificial intelligence to find new drugs, raised $273 million…
The search for new Covid drugs — and a researcher’s reason for optimism
David Fajgenbaum is a physician and scientist at the University of Pennsylvania. He is best…